Oncology
We specialize in the production of innovative oncology research models including PDX models and compound evaluation using PDX or cell line xenograft models, and efficacy testing of cancer immunotherapeutics.
Strain Name | Model Benefits | Strain Considerations | Research Areas | Reference |
---|---|---|---|---|
NSG™ |
|
|
N/A |
|
NSG-SGM3 |
|
|
|
Nicolini et al., 2004 |
NRG |
|
|
|
|
NSG-A2 |
|
|
|
Shultz et al., 2010 |
NSG-HLA-A2/HHD |
|
|
|
Shultz et al., 2010 |
NSG-DR1 |
|
|
|
|
NSG-Abo DR4 |
|
|
|
|
NSG B2m |
|
|
|
|
NSG-(KbDb)null |
|
|
|
|
NSG-MHC I/II DKO |
|
|
|
|
NSG-Tg(Hu-IL15) |
|
|
|
|
NBSGW |
|
|
|
|
NSG-PiZ |
|
|
|
|
NSG-TLR4 KO |
|
|
|
We specialize in the production of innovative oncology research models including PDX models and compound evaluation using PDX or cell line xenograft models, and efficacy testing of cancer immunotherapeutics.
We use cookies to personalize our website and to analyze web traffic to improve the user experience. You may decline these cookies although certain areas of the site may not function without them. Please refer to our privacy policy for more information.
Allow essential cookies
Required for basic site operations.
Allow analytics cookies
Used to analyze web traffic to improve the user experience.
Allow marketing cookies
Used to deliver personalized information and tailor communications.